Table 5.
Variable | Univariate Analysis | Multivariate Analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI (Lower–Upper) | p | HR | 95% CI (Lower–Upper) | p | |
Age (increasing) | 1.011 | 1.004–1.019 | 0.003 | 1.017 | 1.005–1.028 | 0.004 |
Sex, male (female ref.) | 1.364 | 1.060–1.756 | 0.016 | 1.051 | 0.803–1.376 | 0.718 |
BMI (increasing) | 1.095 | 1.073–1.118 | <0.001 | 1.099 | 1.070–1.129 | <0.001 |
ASA Score (increasing) | 1.731 | 1.465–2.046 | <0.001 | 1.085 | 0.843–1.395 | 0.527 |
Increased SUA (dec./stable SUA ref.) | 6.467 | 5.088–8.219 | <0.001 | 4.708 | 3.647–6.078 | <0.001 |
Stage II | 1.541 | 1.152–2.061 | 0.004 | 1.336 | 0.981–1.820 | 0.066 |
Stage III | 2.025 | 1.472–2.785 | <0.001 | 1.537 | 1.095–2.157 | 0.013 |
Stage IV | 7.119 | 4.219–12.014 | <0.001 | 3.299 | 1.919–5.674 | <0.001 |
RN (PN ref.) | 2.172 | 1.600–2.948 | <0.001 | 1.497 | 1.042–2.150 | 0.029 |
de novo CKD stage III | 2.534 | 1.997–3.215 | <0.001 | 1.684 | 1.297–2.186 | <0.001 |
HR, Hazard Ratio.